Septerna, Inc. SEPN 深 滬
已收盤 12-24 16:00:00 美东时间
29.47
+1.240
+4.39%
華盛通- 最 高29.655
- 今 開28.34
- 成交量 11.40万股
- 最 低 28.2579
- 昨 收 28.23
- 總市值 13.13亿
- 52周最高 30.50
- 市盈率 靜 --
- 換手率 0.26%
- 52周最低 4.17
- 委 比 48.69%
- 總股本 4455.83万
- 歷史最高 30.50
- 量 比 0.29
- 振 幅 4.95%
- 歷史最低 4.17
- 每 手 1
- 風險率 6.81%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅63.56%！拜玛林制药获Truist Securities升目标价至100美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持拜玛林制药"买入"评级，目标价从80美元升至100美元；HC Wainwright & Co.：维持Savara"买入"评级，目标价从8美元升至10美元
12-24 11:17
Jones Trading Initiates Coverage On Septerna with Buy Rating, Announces Price Target of $43
Jones Trading analyst Catherine Novack initiates coverage on Septerna (NASDAQ:SEPN) with a Buy rating and announces Price Target of $43.
12-23 22:09
美股大行评级 | 绩后评级出炉！联邦快递获多家大行上调目标价；耐克遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Pyxis Oncology"买入"评级，目标价从5美元升至7美元；Stifel：维持Oculis Holding"买入"评级，目标价从35美元升至40美元
12-22 15:05
Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference
Septerna, Inc., a clinical-stage biotechnology company focused on GPCR drug discovery, announced that CEO Jeffrey Finer, M.D., Ph.D., will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026, at 3:45 p.m. PT in San Francisco. The presentation will be webcast live and archived for 30 days on the company’s website. Septerna develops novel oral small molecule drug candidates using its proprietary Native Complex Platform™...
12-17 13:00
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
12-16 09:36
Truist Securities Initiates Coverage On Septerna with Buy Rating, Announces Price Target of $34
Truist Securities analyst Srikripa Devarakonda initiates coverage on Septerna (NASDAQ:SEPN) with a Buy rating and announces Price Target of $34.
12-15 21:52
Septerna to Participate in 8th Annual Evercore Healthcare Conference
Septerna, Inc., a clinical-stage biotechnology company, announced that its management will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on December 2, 2025, at 10:25 a.m. ET in Coral Gables, Florida. A live webcast will be available on the company’s website, www.septerna.com, and will be archived for at least 30 days. Septerna is advancing GPCR drug discovery with its proprietary Native Complex Platform™, target...
11-25 13:00
美股大行评级 | 花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级
花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>
11-17 10:49
美股周涨跌榜 | 新药取得重大突破！COGT周涨超126%；生物制药公司Cidara周涨逾108%，获默沙东收购
新药取得重大突破！COGT周涨超126%；生物制药公司Cidara周涨逾108%，获默沙东92亿美元收购；REAL周涨超26%，Q3业绩超预期>>
11-15 10:30
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
11-12 11:43
